flesinoxan has been researched along with raclopride in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Audinot, V; Chaput, C; Conte, C; Gavaudan, S; Millan, MJ; Newman-Tancredi, A; Touzard, M; Verrièle, L | 1 |
| Bantick, RA; De Vries, MH; Grasby, PM | 1 |
2 other study(ies) available for flesinoxan and raclopride
| Article | Year |
|---|---|
Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study.
Topics: Animals; Antipsychotic Agents; CHO Cells; Cricetinae; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Agents; Sulfur Radioisotopes | 1998 |
The effect of a 5-HT1A receptor agonist on striatal dopamine release.
Topics: Adult; Binding, Competitive; Carbon Radioisotopes; Catalepsy; Corpus Striatum; Dopamine; Dopamine Antagonists; Growth Hormone; Humans; Male; Middle Aged; Piperazines; Positron-Emission Tomography; Raclopride; Radioligand Assay; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Reference Values; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists; Up-Regulation | 2005 |